Syndax Pharmaceuticals (SNDX) EBIT Margin Growth (3y) (2018 - 2024)
Syndax Pharmaceuticals (SNDX) EBIT Margin Growth (3y) (2018 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Syndax Pharmaceuticals |
1.69 Bn |
1.34 Bn |
53.02 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
-133,040.00 |
| Sep 30, 2024 |
-55,474.00 |
| Jun 30, 2024 |
377,242.00 |
| Dec 31, 2021 |
516,328.00 |
| Sep 30, 2021 |
454,551.00 |
| Jun 30, 2021 |
-89,261.00 |
| Mar 31, 2021 |
-195,567.00 |
| Dec 31, 2020 |
-359,270.00 |
| Sep 30, 2020 |
-17,400.00 |
| Jun 30, 2020 |
15,577.00 |
| Mar 31, 2020 |
33,616.00 |
| Dec 31, 2019 |
-8,537.00 |
| Sep 30, 2019 |
152,667.00 |
| Jun 30, 2019 |
-122,564.00 |
| Mar 31, 2019 |
-103,808.00 |
| Dec 31, 2018 |
-355,353.00 |
| Sep 30, 2018 |
-278,673.00 |
| Jun 30, 2018 |
2.76 Mn |
